Original-Research: Cenit AG (von GBC AG): Buy
Original-Research: Cenit AG - von GBC AG Einstufung von GBC AG zu Cenit AG Unternehmen: Cenit AG ISIN: DE0005407100 Anlass der Studie: Research Comment Empfehlung: Buy Kursziel: 19.75 EUR Kursziel
Stay updated with breaking news from Research Comment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Original-Research: Cenit AG - von GBC AG Einstufung von GBC AG zu Cenit AG Unternehmen: Cenit AG ISIN: DE0005407100 Anlass der Studie: Research Comment Empfehlung: Buy Kursziel: 19.75 EUR Kursziel
Investegate announcements from HAEMATO AG, Original-Research: HAEMATO AG (von GBC AG): BUY
Saying accidents happen from time to time. so 7 million people are dead and the theme is, stuff happens." then she declares that wearing a mask is absolutely effective. as for the highly respected review that concluded masking does not work, dismissed it is saying another writer at the l.a. times already debunked the story. liberal writers, and debunked studies conservative doctors are censored? that is following science. as for the lancet study training natural immunity is more protected than vaccines, this research comment was offered, "it well were off eventually so just take the vaccine." ...
Original-Research: Cenit AG - von GBC AG Einstufung von GBC AG zu Cenit AG Unternehmen: Cenit AG ISIN: DE0005407100 Anlass der Studie: Research Comment Empfehlung: BUY Kursziel: 18.20 EUR Kursziel
Investegate announcements from Cenit AG, Original-Research: Cenit AG (von GBC AG): BUY